Evidence map›Paper›PMID 38586023›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Enhancing Cognitive Performance Prediction through White Matter Hyperintensity Connectivity Assessment: A Multicenter Lesion Network Mapping Analysis of 3,485 Memory Clinic Patients.

Marvin Petersen, Mirthe Coenen, Charles DeCarli, Alberto De Luca, Ewoud van der Lelij, Alzheimer’s Disease Neuroimaging Initiative, Frederik Barkhof, Thomas Benke, Christopher P L H Chen, Peter Dal-Bianco and 32 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors at 14 institutions in 10 countries.

Marvin PetersenDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Mirthe CoenenUniversity Medical Center Utrecht Brain Center, Utrecht, The Netherlands.
Charles DeCarliUniversity of California at Davis, USA.
Alberto De LucaUniversity Medical Center Utrecht Brain Center, Utrecht, The Netherlands.
Ewoud van der LelijUniversity Medical Center Utrecht Brain Center, Utrecht, The Netherlands.
Alzheimer’s Disease Neuroimaging Initiative
Frederik BarkhofDepartment of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, the Netherlands.
Thomas BenkeClinic of Neurology, Medical University Innsbruck, Austria.
Christopher P L H ChenDepartments of Pharmacology and Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Peter Dal-BiancoMedical University Vienna, Austria.
Anna DewenterInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Munich, Germany.
Marco DueringInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Munich, Germany.
Christian EnzingerDivision of General Neurology, Department of Neurology, Medical University Graz, Austria.
Michael EwersInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Munich, Germany.
Lieza G ExaltoUniversity Medical Center Utrecht Brain Center, Utrecht, The Netherlands.
Evan F FletcherUniversity of California at Davis, USA.
Nicolai FranzmeierInstitute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Munich, Germany.
Saima HilalMemory, Aging and Cognition Center, National University Health System, Singapore.
Edith HoferDivision of Neurogeriatrics, Department of Neurology, Medical University of Graz, Austria.
Huiberdina L KoekUniversity Medical Center Utrecht Brain Center, Utrecht, The Netherlands.
Andrea B MaierDepartments of Pharmacology and Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Pauline M MaillardUniversity of California at Davis, USA.
Cheryl R McCrearyDepartment of Clinical Neurosciences and Radiology and Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Janne M PapmaAlzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Yolande A L PijnenburgAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Reinhold SchmidtDivision of Neurogeriatrics, Department of Neurology, Medical University of Graz, Austria.
Eric E SmithDepartment of Clinical Neurosciences and Radiology and Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Rebecca M E SteketeeAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Esther van den BergAlzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Wiesje M van der FlierAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Vikram VenkatraghavanAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Narayanaswamy VenketasubramanianMemory, Aging and Cognition Center, National University Health System, Singapore.
Meike W VernooijAlzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Frank J WoltersDepartment of Radiology & Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Xin XuMemory, Aging and Cognition Center, National University Health System, Singapore.
Andreas HornCharité - Universitätsmedizin Berlin, Movement Disorders and Neuromodulation Unit, Department of Neurology with Experimental Neurology, 10117 Berlin, Germany.
Kaustubh R PatilInstitute for Systems Neuroscience, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Simon B EickhoffInstitute for Systems Neuroscience, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Götz ThomallaDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
J Matthijs BiesbroekUniversity Medical Center Utrecht Brain Center, Utrecht, The Netherlands.
Geert Jan BiesselsUniversity Medical Center Utrecht Brain Center, Utrecht, The Netherlands.
Bastian ChengDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
National University of Singapore · SGUniversity Medical Center Utrecht · NLErasmus MC · NLUniversität Hamburg · DEUniversity of Calgary · CAMedical University of Graz · ATForschungszentrum Jülich · DELMU Klinikum · DENational Hospital for Neurology and Neurosurgery · GBRaffles Institution · SGUniversity of Basel · CHAmsterdam Neuroscience · NLCircuit Therapeutics (United States) · USUniversity of California, Davis · US

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI DECARLI, CHARLES · 1991 to 2020
$28.3M
UC Davis Alzheimer's Disease Research CenterP30AG072972 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEE-WAY JIN · 2021 to 2026
$25.2M
NIA NIH HHS P30 AG010129NIA NIH HHS P30 AG072972NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

Introduction: White matter hyperintensities of presumed vascular origin (WMH) are associated with cognitive impairment and are a key imaging marker in evaluating cognitive health. However, WMH volume alone does not fully account for the extent of cognitive deficits and the mechanisms linking WMH to these deficits remain unclear. We propose that lesion network mapping (LNM), enables to infer if brain networks are connected to lesions, and could be a promising technique for enhancing our understanding of the role of WMH in cognitive disorders. Our study employed this approach to test the following hypotheses: (1) LNM-informed markers surpass WMH volumes in predicting cognitive performance, and (2) WMH contributing to cognitive impairment map to specific brain networks. Methods & results: We analyzed cross-sectional data of 3,485 patients from 10 memory clinic cohorts within the Meta VCI Map Consortium, using harmonized test results in 4 cognitive domains and WMH segmentations. WMH segmentations were registered to a standard space and mapped onto existing normative structural and functional brain connectome data. We employed LNM to quantify WMH connectivity across 480 atlas-based gray and white matter regions of interest (ROI), resulting in ROI-level structural and functional LNM scores. The capacity of total and regional WMH volumes and LNM scores in predicting cognitive function was compared using ridge regression models in a nested cross-validation. LNM scores predicted performance in three cognitive domains (attention and executive function, information processing speed, and verbal memory) significantly better than WMH volumes. LNM scores did not improve prediction for language functions. ROI-level analysis revealed that higher LNM scores, representing greater disruptive effects of WMH on regional connectivity, in gray and white matter regions of the dorsal and ventral attention networks were associated with lower cognitive performance. Conclusion: Measures of WMH-related brain network connectivity significantly improve the prediction of current cognitive performance in memory clinic patients compared to WMH volume as a traditional imaging marker of cerebrovascular disease. This highlights the crucial role of network effects, particularly in attentionrelated brain regions, improving our understanding of vascular contributions to cognitive impairment. Moving forward, refining WMH information with connectivity data could contribute to patient-tailored therapeutic interventions and facilitate the identification of subgroups at risk of cognitive disorders.

Identifiers

PMID38586023
PMCPMC10996741
OpenAlexW4393252255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.